A push-button, automated solution for profiling cell health and death
Nanolive launches another ground-breaking tool in cell analysis: the LIVE Cell Death Assay, a push button, automated solution for profiling cell health, death, apoptosis and necrosis, label-free.
The LIVE Cell Death Assay (LCDA) provides first-in-class cytotoxicity analysis of dynamic label-free live cell data. Developed using state-of-the-art machine learning, the LCDA has been trained to discriminate not only living cells from dead cells, but also apoptosis from necrosis.
The LCDA has been created to be as user-friendly as possible: a single click of a button is required to launch the analysis. It delivers 13 viability and death-related metrics.
Watch the LIVE Cell Death Assay product video below!
Read our latest news
Simplifying drug delivery assessment: Industry perspectives
Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.
Webinar – Investigating nanoparticle delivery with label-free live cell imaging
Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…
Move beyond endpoints with dynamic EC50
Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.